| Literature DB >> 27990146 |
Humira Sonah1, Xuehua Zhang2, Rupesh K Deshmukh1, M Hossein Borhan3, W G Dilantha Fernando2, Richard R Bélanger1.
Abstract
Leptosphaeria maculans is a hemibiotrophic fungus that causes blackleg of canola (Brassica napus), one of the most devastating diseases of this crop. In the present study, transcriptome profiling of L. maculans was performed in an effort to understand and define the pathogenicity genes that govern both the biotrophic and the necrotrophic phase of the fungus, as well as those that separate a compatible from an incompatible interaction. For this purpose, comparative RNA-seq analyses were performed on L. maculans isolate D5 at four different time points following inoculation on susceptible cultivar Topas-DH16516 or resistant introgression line Topas-Rlm2. Analysis of 1.6 billion Illumina reads readily identified differentially expressed genes that were over represented by candidate secretory effector proteins, CAZymes, and other pathogenicity genes. Comparisons between the compatible and incompatible interactions led to the identification of 28 effector proteins whose chronology and level of expression suggested a role in the establishment and maintenance of biotrophy with the plant. These included all known Avr genes of isolate D5 along with eight newly characterized effectors. In addition, another 15 effector proteins were found to be exclusively expressed during the necrotrophic phase of the fungus, which supports the concept that L. maculans has a separate and distinct arsenal contributing to each phase. As for CAZymes, they were often highly expressed at 3 dpi but with no difference in expression between the compatible and incompatible interactions, indicating that other factors were necessary to determine the outcome of the interaction. However, their significantly higher expression at 11 dpi in the compatible interaction confirmed that they contributed to the necrotrophic phase of the fungus. A notable exception was LysM genes whose high expression was singularly observed on the susceptible host at 7 dpi. In the case of TFs, their higher expression at 7 and 11 dpi on susceptible Topas support an important role in regulating the genes involved in the different pathogenic phases of L. maculans. In conclusion, comparison of the transcriptome of L. maculans during compatible and incompatible interactions has led to the identification of key pathogenicity genes that regulate not only the fate of the interaction but also lifestyle transitions of the fungus.Entities:
Keywords: Avr genes; CAZymes; RNA-seq transcriptome profiling; compatible interactions; effectors; incompatible interactions
Year: 2016 PMID: 27990146 PMCID: PMC5131014 DOI: 10.3389/fpls.2016.01784
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Figure 1Disease symptoms at 11 days post inoculation on leaves of compatible (Topas-wild) and incompatible (Topas.
Figure 2Percentage of mapped reads to the . RNA-seq was performed for L. maculans isolate D5 inoculated to Topas-wild (compatible) and Topas-Rlm2 (incompatible) canola genotypes.
Figure 3Principal components (PCs) of RNA-seq expression profile obtained for . A total of five biological replications for 3, 5, 7, and 11 days post inoculation (dpi) were used for RNA-seq expression profiling of L. maculans inoculated to compatible host Topas-wild (blue) and incompatible host Topas-Rlm2 (Red).
Figure 4Differentially expressed . Differentially expressed genes were identified by comparing in planta samples with axenic cultures. Analyses were performed with five biological replicates and a threshold value of FDR < 0.0001 and log2 fold-change > 1.5.
List of the top 20 upregulated .
| Gene_11912 | lm_SuperContig_8_v2:1610355–1610701 | 12276 | 1400.46 | 13.04 | 0.00E+00 | Hypothetical protein | |
| Gene_4884 | lm_SuperContig_18_v2:862571–862990 | 14727 | 2585.81 | 10.89 | 0.00E+00 | Hypothetical protein | |
| Gene_9702 | lm_SuperContig_5_v2:114784–120578 | 1424 | 229.89 | 10.79 | 0.00E+00 | Chitin binding/Carbohydrate-Binding Module Family 18 | |
| Gene_1799 | lm_SuperContig_11_v2:702412–703074 | 8854 | 1176.77 | 10.36 | 0.00E+00 | Hypothetical protein (CSEP) | |
| Gene_8310 | lm_SuperContig_2_v2:2602620–2603501 | 1040 | 261.13 | 10.24 | 7.00E-159 | Hypothetical protein | |
| Gene_11624 | lm_SuperContig_8_v2:828284–829346 | 1890 | 257.48 | 10 | 0.00E+00 | Hypothetical protein SSP(Effector) | |
| Gene_6862 | lm_SuperContig_21_v2:752639–754522 | 1097 | 214.03 | 9.74 | 0.00E+00 | G-protein coupled receptor activity | |
| Gene_2936 | lm_SuperContig_14_v2:218210–219154 | 1330 | 153.58 | 9.56 | 0.00E+00 | Hypothetical protein | |
| Gene_9395 | lm_SuperContig_4_v2:1136979–1138783 | 1911 | 277.28 | 9.48 | 0.00E+00 | Alcohol dehydrogenase | |
| Gene_6482 | lm_SuperContig_20_v2:529112–533279 (-) | 6078 | 667.23 | 8.52 | 0.00E+00 | Hypothetical protein | |
| Gene_8982 | lm_SuperContig_3_v2:2203740–2205537 | 1054 | 150.79 | 8 | 0.00E+00 | Transporter activity | |
| Gene_11976 | lm_SuperContig_8_v2:1760041–1760879 | 2812 | 828.34 | 7.86 | 0.00E+00 | Fasciclin and related adhesion glycoproteins | |
| Gene_7649 | lm_SuperContig_2_v2:804099–805458 | 1215 | 335.02 | 7.7 | 0.00E+00 | Predicted transporter | |
| Gene_11804 | lm_SuperContig_8_v2:1317923–1319474 | 1108 | 232.60 | 7.65 | Hypothetical protein SSP(Effector) | ||
| Gene_5070 | lm_SuperContig_19_v2:299282–300301 | 1331 | 384.38 | 7.19 | 9.90E-111 | Hypothetical protein | |
| Gene_3811 | lm_SuperContig_15_v2:1293850–1295649 | 1757 | 427.33 | 7.14 | 0.00E+00 | Transporter activity | |
| Gene_5572 | lm_SuperContig_1_v2:975571–976381 | 1529 | 191.58 | 6.44 | 0.00E+00 | Hypothetical protein | |
| Gene_6173 | lm_SuperContig_1_v2:2566440–2566907 | 1504 | 256.68 | 6.41 | 5.90E-221 | Hypothetical protein | |
| Gene_2652 | lm_SuperContig_13_v2:633177–634702 | 2616 | 398.51 | 6.26 | 0.00E+00 | Hypothetical protein | |
| Gene_1331 | lm_SuperContig_10_v2:445682–445936 | 1122 | 371.94 | 6.22 | 0.00E+00 | Hypothetical protein | |
| Gene_4884 | lm_SuperContig_18_v2:862571–862990 | 33992 | 1715.82 | 13.06 | 0.00E+00 | Hypothetical protein | |
| Gene_10161 | lm_SuperContig_5_v2:1424583–1425111 | 1399 | 427.40 | 12.98 | 2.50E-90 | Hypothetical protein | |
| Gene_2216 | lm_SuperContig_12_v2:827863–828642 | 1931 | 368.22 | 11.52 | 3.90E-96 | Predicted protein SSP(Effector) | |
| Gene_10273 | lm_SuperContig_5_v2:1712896–1714128 | 1282 | 381.49 | 11.44 | 0.00E+00 | Transcription factor | |
| Gene_8310 | lm_SuperContig_2_v2:2602620–2603501 | 1143 | 435.53 | 11.34 | 2.20E-214 | Oxidoreductase activity | |
| Gene_9395 | lm_SuperContig_4_v2:1136979–1138783 | 1072 | 263.45 | 9.61 | 0.00E+00 | Alcohol dehydrogenase | |
| Gene_11804 | lm_SuperContig_8_v2:1317923–1319474 | 2104 | 547.85 | 9.55 | 0.00E+00 | Hypothetical protein (CSEP) | |
| Gene_6173 | lm_SuperContig_1_v2:2566440–2566907 | 4527 | 730.72 | 8.97 | 0.00E+00 | Hypothetical protein | |
| Gene_6375 | lm_SuperContig_20_v2:228262–228840 | 1117 | 482.45 | 8.47 | 1.60E-196 | Hypothetical protein (CSEP) | |
| Gene_1799 | lm_SuperContig_11_v2:702412–703074 | 1209 | 279.42 | 8.46 | 1.70E-289 | Hypothetical protein (CSEP) | |
| Gene_11976 | lm_SuperContig_8_v2:1760041–1760879 | 1441 | 225.72 | 7.87 | 0.00E+00 | Fasciclin and related adhesion glycoproteins | |
| Gene_6483 | lm_SuperContig_20_v2:534387–534664 | 1243 | 384.15 | 7.2 | 0.00E+00 | Hypothetical protein | |
| Gene_8491 | lm_SuperContig_3_v2:491445–491728 | 1283 | 356.20 | 6.66 | 3.50E-20 | Hypothetical protein | |
| Gene_1613 | lm_SuperContig_10_v2:1509441–1509941 | 2525 | 1043.94 | 6.4 | 7.30E-75 | Hypothetical protein (CSEP) | |
| Gene_616 | lm_SuperContig_0_v2:2286680–2287371 | 1062 | 295.59 | 6.35 | 5.50E-208 | Hypothetical protein | |
| Gene_7940 | lm_SuperContig_2_v2:1614035–1614898 | 4379 | 1327.86 | 6.33 | 0.00E+00 | Transporter activity | |
| Gene_415 | lm_SuperContig_0_v2:1345345–1345518 | 1090 | 232.24 | 6.14 | 0.00E+00 | Aminotransferase/Catalytic activity | |
| Gene_6466 | lm_SuperContig_20_v2:490947–492054 | 1030 | 361.07 | 5.94 | 1.90E-196 | Ion channel activity | |
| Gene_2652 | lm_SuperContig_13_v2:633177–634702 | 1060 | 337.82 | 5.92 | 4.20E-292 | Hypothetical protein | |
| Gene_234 | lm_SuperContig_0_v2:882882–883215 | 1670 | 221.35 | 5.58 | 1.00E-18 | Hypothetical protein | |
| Gene_6534 | lm_SuperContig_20_v2:655034–655196 | 18463 | 3470.09 | 18.02 | 1.30E-126 | Predicted protein | |
| Gene_10161 | lm_SuperContig_5_v2:1424583–1425111 | 2763 | 185.07 | 13.08 | 1.30E-130 | Hypothetical protein | |
| Gene_2216 | lm_SuperContig_12_v2:827863–828642 | 5389 | 739.19 | 12.12 | 3.80E-162 | Predicted protein SSP(Effector) | |
| Gene_1515 | lm_SuperContig_10_v2:1026907–1027349 | 1157 | 262.25 | 11.46 | 2.50E-193 | Hypothetical protein | |
| Gene_8929 | lm_SuperContig_3_v2:1850027–1850254 | 3062 | 510.96 | 11.38 | 6.90E-256 | Hypothetical protein | |
| Gene_11912 | lm_SuperContig_8_v2:1610355–1610701 | 2410 | 453.43 | 10.77 | 1.20E-221 | Hypothetical protein | |
| Gene_2066 | lm_SuperContig_12_v2:398032–399219 | 2890 | 507.44 | 10.73 | 7.10E-274 | Hypothetical protein | |
| Gene_8487 | lm_SuperContig_3_v2:287922–288676 | 5468 | 1962.05 | 10.62 | 0.00E+00 | Hypothetical protein (CSEP) | |
| Gene_10780 | lm_SuperContig_6_v2:1607018–1607681 | 3553 | 316.20 | 9.31 | 0.00E+00 | Hypothetical protein (AvrLm1) | |
| Gene_170 | lm_SuperContig_0_v2:571327–571980 | 1695 | 466.93 | 9.31 | 0.00E+00 | Hypothetical protein (CSEP) | |
| Gene_6375 | lm_SuperContig_20_v2:228262–228840 | 3556 | 1067.76 | 9.26 | 0.00E+00 | Hypothetical protein (CSEP) | |
| Gene_9004 | lm_SuperContig_3_v2:2336899–2337410 | 23963 | 3704.18 | 9.06 | 0.00E+00 | Hypothetical protein (CSEP) | |
| Gene_616 | lm_SuperContig_0_v2:2286680–2287371 | 9230 | 1311.26 | 8.58 | 0.00E+00 | Hypothetical protein | |
| Gene_4884 | lm_SuperContig_18_v2:862571–862990 | 1940 | 697.48 | 8.04 | 4.40E-135 | Hypothetical protein | |
| Gene_2397 | lm_SuperContig_12_v2:1374587–1375064 | 2131 | 209.12 | 8.04 | 0.00E+00 | Hypothetical protein (AvrLm4-7) | |
| Gene_1613 | lm_SuperContig_10_v2:1509441–1509941 | 11945 | 2426.45 | 7.76 | 0.00E+00 | Hypothetical protein (CSEP) | |
| Gene_7362 | lm_SuperContig_25_v2:296506–296973 | 1952 | 519.68 | 7.66 | 5.40E-226 | Hypothetical protein (CSEP) | |
| Gene_234 | lm_SuperContig_0_v2:882882–883215 | 12153 | 4475.87 | 7.56 | 0.00E+00 | Hypothetical protein | |
| Gene_1799 | lm_SuperContig_11_v2:702412–703074 | 1064 | 240.87 | 7.38 | 0.00E+00 | Hypothetical protein (CSEP) | |
| Gene_6961 | lm_SuperContig_22_v2:294086–294450 | 6654 | 1114.42 | 6.32 | 0.00E+00 | Hypothetical protein (AvrLm11) | |
| Gene_11177 | lm_SuperContig_7_v2:982889–983113 | 6770 | 895.39 | 5.79 | 0.00E+00 | Hypothetical protein (AvrLmJ1) | |
| Gene_9481 | lm_SuperContig_4_v2:1367322–1368521 | 2280 | 179.23 | 13.5 | 0.00E+00 | Vacuolar protein sorting-associated protein | |
| Gene_10161 | lm_SuperContig_5_v2:1424583–1425111 | 1760 | 173.39 | 12.26 | 6.50E-123 | Hypothetical protein | |
| Gene_7308 | lm_SuperContig_25_v2:145516–147997 | 1128 | 265.94 | 10.79 | 0.00E+00 | Glucose dehydrogenase | |
| Gene_2216 | lm_SuperContig_12_v2:827863–828642 | 1906 | 121.93 | 10.46 | 1.50E-131 | Predicted protein SSP(Effector) | |
| Gene_11875 | lm_SuperContig_8_v2:1510198–1511697 | 1484 | 458.66 | 10.25 | 0.00E+00 | Peptidase S26A, signal peptidase I/Proteolysis | |
| Gene_2066 | lm_SuperContig_12_v2:398032–399219 | 1316 | 182.72 | 9.44 | 1.20E-212 | Hypothetical protein | |
| Gene_11099 | lm_SuperContig_7_v2:754032–755352 | 2233 | 136.92 | 9.05 | 0.00E+00 | Peptidoglycan-binding LysM (Lm5LysM) | |
| Gene_170 | lm_SuperContig_0_v2:571327–571980 | 1377 | 101.99 | 8.84 | 0.00E+00 | Hypothetical protein (CSEP) | |
| Gene_12054 | lm_SuperContig_9_v2:365423–366979 | 1857 | 106.76 | 8.42 | 0.00E+00 | 3-dehydroquinate synthase activity | |
| Gene_10765 | lm_SuperContig_6_v2:1209331–1209753 | 15579 | 1656.89 | 8.12 | 1.40E-127 | Hypothetical protein | |
| Gene_616 | lm_SuperContig_0_v2:2286680–2287371 | 5059 | 356.09 | 7.55 | 0.00E+00 | Hypothetical protein | |
| Gene_10767 | lm_SuperContig_6_v2:1211326–1212274 | 2212 | 253.35 | 7.23 | 0.00E+00 | Glucose/ribitol dehydrogenase | |
| Gene_1012 | lm_SuperContig_0_v2:3437723–3438128 | 1319 | 310.89 | 7.13 | 2.50E-235 | Hypothetical protein (CSEP) | |
| Gene_9092 | lm_SuperContig_4_v2:302019–302430 | 12896 | 2333.41 | 7.08 | 4.20E-155 | Response to stress | |
| Gene_304 | lm_SuperContig_0_v2:1104438–1107822 | 1149 | 150.74 | 6.8 | 2.70E-294 | Haloacid dehalogenase-like hydrolase | |
| Gene_11976 | lm_SuperContig_8_v2:1760041–1760879 | 1061 | 112.38 | 6.37 | 6.70E-263 | Fasciclin and related adhesion glycoproteins | |
| Gene_7609 | lm_SuperContig_2_v2:575802–582958 | 3787 | 960.67 | 6.09 | 1.10E-83 | Hypothetical protein | |
| Gene_6173 | lm_SuperContig_1_v2:2566440–2566907 | 1252 | 141.60 | 6.06 | 4.20E-177 | Hypothetical protein | |
| Gene_9004 | lm_SuperContig_3_v2:2336899–2337410 | 2751 | 214.78 | 5.78 | 0.00E+00 | Hypothetical protein (CSEP) | |
| Gene_368 | lm_SuperContig_0_v2:1246649–1246843 | 1027 | 216.39 | 5.24 | 4.00E-198 | Hypothetical protein (CSEP) | |
| Gene_1613 | lm_SuperContig_10_v2:1509441–1509941 | 2195 | 113.31 | 5.15 | 6.30E-275 | Hypothetical protein (CSEP) | |
| Gene_3471 | lm_SuperContig_15_v2:160448–161311 | 746 | 150.76 | 7.37 | 1.30E-257 | Cutinase/catalytic activity | |
The fold change was estimated by comparing in planta gene expression at 3, 5, 7, and 11 days post inoculation (dpi) with axenic cultures of L. maculans.
Analyses were performed with five biological replicates. dpi, days post inoculation; FPKM, Fragments per kilobase of transcript per million mapped reads; FC, fold-change; SE, Standard error for FPKM.
Figure 5Heat map of time series analysis showing expression pattern of the top 22 genes in . Gene_2397, gene_10780, and gene_11099 represents AvrLm4-7, AvrLm1, and Lm5LysM, respectively. Analyses were performed with five biological replicates.
Figure 6Number of upregulated candidate small secretory effector proteins (CSEPs) identified by RNA-seq analyses performed in . Upregulated genes were identified by comparing in planta samples at different growth stages with axenic cultures. dpi, days post inoculation. Analyses were performed with five biological replicates and a threshold value of FDR < 0.0001 and log2 fold-change > 1.5.
Expression pattern of 28 effector proteins, including known .
| Gene_9004 | 0.0 | 122.3 | 23963.3 | 2751.1 | 0.0 | 106.3 | 257.6 | 38.1 | 1 | ||
| Gene_1613 | 161.7 | 2525.2 | 11944.8 | 2194.9 | 79.6 | 1065.7 | 1667.9 | 435.4 | 1 | ||
| Gene_1720 | 0.0 | 299.4 | 8458.8 | 2802.2 | 7.9 | 744.5 | 1618.6 | 1428.4 | 1 | ||
| Gene_11177 | 77.5 | 928.2 | 6769.7 | 2786.3 | 10.6 | 106.3 | 487.2 | 375.2 | 1.2 | ||
| Gene_6961 | 51.0 | 1646.3 | 6653.6 | 1346.6 | 32.0 | 899.8 | 627.7 | 263.3 | 2 | ||
| Gene_8487 | 82.9 | 1626.7 | 5468.1 | 728.6 | 91.9 | 463.7 | 322.1 | 58.5 | 1 | ||
| Gene_12203 | 361.8 | 939.2 | 4087.3 | 3933.3 | 350.5 | 1046.2 | 470.3 | 385.3 | |||
| Gene_2817 | 32.0 | 32.3 | 3930.2 | 1420.1 | 30.6 | 354.6 | 679.8 | 164.6 | 1 | ||
| Gene_6375 | 67.4 | 1117.1 | 3555.8 | 959.4 | 23.7 | 437.1 | 627.4 | 188.6 | 1 | ||
| Gene_10780 | 57.3 | 673.4 | 3553.0 | 875.5 | 29.0 | 108.0 | 205.8 | 134.1 | 2 | ||
| Gene_7223 | 61.1 | 448.7 | 2982.2 | 1139.6 | 71.0 | 323.9 | 211.3 | 291.7 | 1 | ||
| Gene_6114 | 14.5 | 937.1 | 2479.8 | 722.8 | 14.4 | 145.6 | 8.9 | 71.3 | 1 | ||
| Gene_2397 | 23.6 | 237.1 | 2130.8 | 859.7 | 18.8 | 64.8 | 134.7 | 116.7 | 2 | ||
| Gene_7362 | 0.0 | 87.8 | 1952.3 | 412.2 | 0.0 | 232.6 | 93.3 | 308.9 | 2 | ||
| Gene_1698 | 15.8 | 411.8 | 1775.8 | 607.6 | 18.6 | 230.1 | 110.7 | 118.2 | 1 | ||
| Gene_170 | 0.0 | 41.2 | 1695.1 | 1377.3 | 17.5 | 297.1 | 289.5 | 150.6 | |||
| Gene_6860 | 385.1 | 636.1 | 1551.7 | 918.3 | 325.5 | 351.1 | 233.1 | 192.1 | 1 | ||
| Gene_2728 | 0.5 | 1.6 | 804.9 | 112.6 | 17.7 | 49.6 | 124.6 | 141.4 | |||
| Gene_5357 | 225.6 | 210.0 | 574.7 | 236.9 | 137.6 | 65.9 | 43.7 | 21.3 | |||
| Gene_10809 | 0.0 | 62.8 | 526.2 | 154.7 | 5.2 | 12.4 | 20.3 | 20.2 | 1 | ||
| Gene_8681 | 0.0 | 296.1 | 466 | 56.8 | 0.0 | 75.9 | 83.1 | 157.4 | 1 | ||
| Gene_7202 | 19.3 | 116.8 | 453.4 | 211.5 | 7.3 | 45.3 | 22.4 | 49.2 | |||
| Gene_7203 | 0.0 | 85.6 | 435.3 | 97.3 | 0.0 | 18.0 | 59.7 | 0.0 | 1.2 | ||
| Gene_3097 | 48.1 | 40.4 | 369.8 | 155.8 | 59.6 | 219.7 | 185.9 | 66.1 | 1 | ||
| Gene_11572 | 0.0 | 0.0 | 300.2 | 3.7 | 0.0 | 17.5 | 225.4 | 0.0 | |||
| Gene_9602 | 0.0 | 56.1 | 136.2 | 54.6 | 0.0 | 19.9 | 3.3 | 1.1 | 1 | ||
| Gene_11574 | 0.0 | 0.0 | 130.6 | 2.9 | 0.0 | 0.0 | 110.4 | 16.6 | |||
| Gene_11156 | 57.9 | 30.8 | 89.1 | 25.1 | 22.5 | 5.3 | 3.5 | 9.2 | |||
RNA-seq analysis was performed for L. maculans isolate D5 inoculated to Topas-wild (compatible) and Topas-Rlm2 (incompatible) canola genotypes.
Analyses were performed with five biological replicates. dpi, days post inoculation; FPKM, Fragments per kilo-base of transcript per million mapped reads; 1, (Haddadi et al., .
Figure 7Expression pattern of known . FPKM, Fragments per kilo-base of transcript per million mapped reads; dpi, days post inoculation. Analyses were performed with five biological replicates.
Expression pattern of 15 effector proteins highly expressed during the necrotrophic phase of a compatible interaction of .
| Gene_8419 | 62.8 | 21.6 | 230.5 | 4859.8 | 47.2 | 112.1 | 409.5 | 223.9 | |
| Gene_6367 | 0.0 | 130.8 | 611.8 | 2132.9 | 46.1 | 265.2 | 325.7 | 184.8 | |
| Gene_368 | 237.6 | 357.1 | 74.3 | 1026.7 | 215.5 | 243.9 | 0.0 | 318.7 | |
| Gene_3948 | 0.0 | 0.0 | 36.6 | 829.0 | 20.0 | 0.0 | 110.7 | 2.2 | |
| Gene_4618 | 1.0 | 0.0 | 197.2 | 338.5 | 1.2 | 0.0 | 0.0 | 89.5 | |
| Gene_8514 | 8.5 | 11.1 | 34.2 | 258.5 | 9.5 | 201.0 | 72.1 | 150.0 | |
| Gene_2889 | 0.0 | 11.6 | 16.7 | 224.8 | 0.0 | 50.0 | 0.0 | 4.4 | |
| Gene_11386 | 19.0 | 15.1 | 156.2 | 202.1 | 37.9 | 21.1 | 34.0 | 16.1 | |
| Gene_776 | 54.7 | 55.9 | 45.3 | 178.5 | 44.6 | 109.6 | 60.7 | 90.8 | |
| Gene_387 | 7.3 | 21.3 | 99.0 | 174.5 | 43.8 | 72.1 | 44.1 | 85.2 | |
| Gene_775 | 37.0 | 0.0 | 32.6 | 99.1 | 31.9 | 49.7 | 65.1 | 34.4 | |
| Gene_588 | 16.7 | 25.2 | 67.5 | 97.2 | 24.8 | 31.7 | 10.0 | 4.5 | |
| Gene_1689 | 16.6 | 6.2 | 26.3 | 56.8 | 25.2 | 34.7 | 8.6 | 13.7 | |
| Gene_8091 | 27.5 | 4.4 | 27.4 | 45.4 | 28.4 | 4.2 | 27.1 | 4.5 | |
| Gene_4923 | 13.0 | 4.7 | 57.3 | 61.9 | 9.9 | 6.3 | 32.3 | 3.1 | |
Analyses were performed with five biological replicates. dpi, days post inoculation; FPKM, Fragments per kilo-base of transcript per million mapped reads.
Figure 8Number of transcription factors (TFs) upregulated in . Upregulated genes were identified by comparing in planta samples at different growth stages with axenic cultures. Analyses were performed with five biological replicates and a threshold value of FDR < 0.0001 and log2 fold-change > 1.5.
Figure 9Number of carbohydrate active enzymes (CAZymes) upregulated at 3, 5, 7, and 11 days post inoculation (dpi) of . Upregulated genes were identified by comparing in planta samples with axenic cultures. Analyses were performed with five biological replicates and a threshold value of FDR < 0.0001 and log2 fold-change > 1.5.
Figure 10Number of upregulated peptidases observed at 3, 5, 7, and 11 days post inoculation (dpi) of . Upregulated genes were identified by comparing in planta samples with axenic cultures. Analyses were performed with five biological replicates and a threshold value of FDR < 0.0001 and log2 fold-change > 1.5.
Figure 11Functional categorization of upregulated genes at 7 days post inoculation (dpi) during compatible and incompatible canola-. The right y-axis indicates the number of genes in a category. The left y-axis indicates the percentage of a specific category of genes in the main category. Upregulated genes were identified by comparing in planta samples with axenic cultures. Analyses were performed with five biological replicates and a threshold value of FDR < 0.0001 and log2 fold-change > 1.5.